HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Michele T Yip-Schneider Selected Research
Michele T Yip-Schneider Research Topics
Disease
19
Pancreatic Neoplasms (Pancreatic Cancer)
01/2023 - 03/2003
19
Neoplasms (Cancer)
01/2023 - 03/2003
11
Pancreatic Cyst
02/2021 - 02/2008
8
Neoplasms, Cystic, Mucinous, and Serous
02/2021 - 03/2011
7
Hepatocellular Carcinoma (Hepatoma)
04/2010 - 03/2004
6
Carcinogenesis
01/2021 - 01/2002
6
Adenocarcinoma
01/2020 - 01/2002
4
Cysts
02/2021 - 04/2014
2
Neoplasm Metastasis (Metastasis)
04/2013 - 10/2008
1
Insulin Resistance
01/2019
1
Pancreatitis
01/2019
1
Margins of Excision
01/2019
1
Chronic Pancreatitis
10/2017
1
Pancreatic Diseases (Pancreatic Disease)
03/2012
1
Cholangiocarcinoma
11/2009
1
Fibrosis (Cirrhosis)
06/2009
1
Hepatitis
06/2009
1
Lung Neoplasms (Lung Cancer)
11/2007
1
Liver Neoplasms (Liver Cancer)
01/2006
1
Transitional Cell Carcinoma
01/2002
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2002
Drug/Important Bio-Agent (IBA)
10
Biomarkers (Surrogate Marker)
IBA
02/2021 - 04/2014
7
Sulindac (Copal)
FDA Link
Generic
01/2013 - 03/2003
7
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
04/2010 - 11/2003
6
Proteins (Proteins, Gene)
FDA Link
02/2021 - 01/2002
5
NF-kappa B (NF-kB)
IBA
04/2013 - 04/2005
4
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
02/2021 - 04/2014
4
Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
IBA
10/2017 - 03/2003
4
parthenolide
IBA
12/2013 - 04/2005
4
Gemcitabine
FDA Link
04/2013 - 02/2008
4
Carcinogens
IBA
11/2009 - 06/2006
3
Carcinoembryonic Antigen
IBA
01/2021 - 05/2017
3
DNA (Deoxyribonucleic Acid)
IBA
01/2021 - 10/2018
3
Dinoprostone (PGE2)
FDA Link
01/2019 - 06/2006
3
Transcription Factors (Transcription Factor)
IBA
04/2013 - 04/2005
3
Cyclooxygenase 2 (Cyclooxygenase-2)
IBA
01/2013 - 06/2006
2
Glucose (Dextrose)
FDA Link
Generic
01/2021 - 01/2018
2
Enzymes
IBA
01/2019 - 01/2002
2
Indicators and Reagents (Reagents)
IBA
10/2017 - 02/2008
2
LC-1 compound
IBA
07/2012 - 10/2008
2
mirdametinib
IBA
04/2010 - 01/2008
2
Transforming Growth Factor alpha (TGF-alpha)
IBA
06/2009 - 01/2008
2
Mitogen-Activated Protein Kinases
IBA
06/2009 - 03/2004
2
U 0126 (UO 126)
IBA
06/2009 - 11/2003
2
2- (2- chloro- 4- iodophenylamino)- N- cyclopropylmethoxy- 3,4- difluoro- 5- bromobenzamide
IBA
06/2009 - 01/2006
2
Celecoxib (Celebrex)
FDA Link
10/2008 - 11/2007
2
Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
IBA
10/2008 - 06/2006
2
Prostaglandins
IBA
02/2008 - 11/2007
2
Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)
IBA
06/2007 - 06/2006
1
MicroRNAs (MicroRNA)
IBA
01/2023
1
human VEGFA protein
IBA
02/2021
1
Protein Isoforms (Isoforms)
IBA
02/2021
1
Codon (Codons)
IBA
01/2021
1
Mucins
IBA
01/2021
1
Amylases
FDA Link
01/2021
1
Tissue Inhibitor of Metalloproteinase-1
IBA
01/2020
1
Glycoproteins (Glycoprotein)
IBA
01/2019
1
Immunosorbents
IBA
01/2019
1
Inosine Monophosphate (IMP)
IBA
01/2019
1
Interleukins
IBA
01/2019
1
Carbohydrates
IBA
01/2019
1
Antigens
IBA
01/2019
1
Branched-Chain Amino Acids
IBA
01/2019
1
CA-19-9 Antigen (CA 19-9 Antigen)
IBA
01/2019
1
Leptin
IBA
01/2019
1
gastricsin
IBA
08/2017
1
Peptide Hydrolases (Proteases)
FDA Link
08/2017
1
Cathepsin E
IBA
08/2017
1
Aspartic Acid Proteases
IBA
08/2017
1
Circulating Tumor DNA
IBA
01/2017
1
Esters
IBA
10/2015
1
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
04/2014
1
Dihydrotachysterol (AT 10)
IBA
12/2013
1
Proteome
IBA
03/2012
1
Secretin
FDA Link
03/2012
1
Cytochrome P-450 CYP2E1 (CYP2E1)
IBA
12/2011
1
Transforming Growth Factors (Transforming Growth Factor)
IBA
03/2011
1
Ethanol (Ethyl Alcohol)
IBA
06/2009
1
Mitogen-Activated Protein Kinase 3
IBA
06/2009
1
1,3-butadiene (divinyl)
IBA
06/2009
1
Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
IBA
06/2009
1
lymphotactin
IBA
10/2008
1
Antineoplastic Agents (Antineoplastics)
IBA
10/2008
1
Prostaglandins E
IBA
02/2008
1
Cyclin D1
IBA
06/2007
1
N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamide
IBA
06/2006
1
2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- one
IBA
03/2003
1
Phosphatidylinositols (Phosphatidylinositol)
IBA
03/2003
Therapy/Procedure
3
Chemoprevention
04/2013 - 01/2008
3
Drug Therapy (Chemotherapy)
04/2013 - 06/2006
3
Therapeutics
06/2007 - 03/2003
1
Pancreatectomy
01/2019
1
Combination Drug Therapy (Combination Chemotherapy)
06/2007
1
Oral Administration
06/2006